BDSI prices $15 million private placement BioDelivery Sciences International, Inc. announces that it offers received definitive commitments from institutional traders for an exclusive placement funding yielding gross proceeds of $15 million to BDSI.12 per talk about, representing a 10 percent price cut to an arranged volume weighted average cost of BDSI’s share nizagara efectos secundarios .S. Exchange and Securities Commission. Arises from this financing are anticipated to be utilized to advance the clinical advancement of BDSI’s pipeline of items, bEMA Buprenorphine and BEMA Buprenorphine/Naloxone particularly. William Blair & Organization, LLC acted because the exclusive positioning agent for the providing. BDSI also announces it provides filed its Annual Record with the SEC on Type 10-K for the fiscal season ended December 31, 2010.